Global Synovial Sarcoma Treatment Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Synovial Sarcoma Treatment

• 1.1 Definition of Synovial Sarcoma Treatment
• 1.2 Synovial Sarcoma Treatment Segment by Type
  • 1.2.1 Global Synovial Sarcoma Treatment Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 ACXT-3102
  • 1.2.3 AL-3818
  • 1.2.4 Axitinib
  • 1.2.5 CMB-305
  • 1.2.6 CUE-102
  • 1.2.7 Others
• 1.3 Synovial Sarcoma Treatment Segment by Applications
  • 1.3.1 Global Synovial Sarcoma Treatment Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Global Synovial Sarcoma Treatment Overall Market
  • 1.4.1 Global Synovial Sarcoma Treatment Revenue (2014-2025)
  • 1.4.2 Global Synovial Sarcoma Treatment Production (2014-2025)
  • 1.4.3 North America Synovial Sarcoma Treatment Status and Prospect (2014-2025)
  • 1.4.4 Europe Synovial Sarcoma Treatment Status and Prospect (2014-2025)
  • 1.4.5 China Synovial Sarcoma Treatment Status and Prospect (2014-2025)
  • 1.4.6 Japan Synovial Sarcoma Treatment Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Synovial Sarcoma Treatment Status and Prospect (2014-2025)
  • 1.4.8 India Synovial Sarcoma Treatment Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Synovial Sarcoma Treatment
• 2.3 Manufacturing Process Analysis of Synovial Sarcoma Treatment
• 2.4 Industry Chain Structure of Synovial Sarcoma Treatment

3 Development and Manufacturing Plants Analysis of Synovial Sarcoma Treatment

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Synovial Sarcoma Treatment Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Synovial Sarcoma Treatment
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Synovial Sarcoma Treatment Production and Capacity Analysis
• 4.2 Synovial Sarcoma Treatment Revenue Analysis
• 4.3 Synovial Sarcoma Treatment Price Analysis
• 4.4 Market Concentration Degree

5 Synovial Sarcoma Treatment Regional Market Analysis

• 5.1 Synovial Sarcoma Treatment Production by Regions
  • 5.1.1 Global Synovial Sarcoma Treatment Production by Regions
  • 5.1.2 Global Synovial Sarcoma Treatment Revenue by Regions
• 5.2 Synovial Sarcoma Treatment Consumption by Regions
• 5.3 North America Synovial Sarcoma Treatment Market Analysis
  • 5.3.1 North America Synovial Sarcoma Treatment Production
  • 5.3.2 North America Synovial Sarcoma Treatment Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Synovial Sarcoma Treatment Import and Export
• 5.4 Europe Synovial Sarcoma Treatment Market Analysis
  • 5.4.1 Europe Synovial Sarcoma Treatment Production
  • 5.4.2 Europe Synovial Sarcoma Treatment Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Synovial Sarcoma Treatment Import and Export
• 5.5 China Synovial Sarcoma Treatment Market Analysis
  • 5.5.1 China Synovial Sarcoma Treatment Production
  • 5.5.2 China Synovial Sarcoma Treatment Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Synovial Sarcoma Treatment Import and Export
• 5.6 Japan Synovial Sarcoma Treatment Market Analysis
  • 5.6.1 Japan Synovial Sarcoma Treatment Production
  • 5.6.2 Japan Synovial Sarcoma Treatment Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Synovial Sarcoma Treatment Import and Export
• 5.7 Southeast Asia Synovial Sarcoma Treatment Market Analysis
  • 5.7.1 Southeast Asia Synovial Sarcoma Treatment Production
  • 5.7.2 Southeast Asia Synovial Sarcoma Treatment Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Synovial Sarcoma Treatment Import and Export
• 5.8 India Synovial Sarcoma Treatment Market Analysis
  • 5.8.1 India Synovial Sarcoma Treatment Production
  • 5.8.2 India Synovial Sarcoma Treatment Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Synovial Sarcoma Treatment Import and Export

6 Synovial Sarcoma Treatment Segment Market Analysis (by Type)

• 6.1 Global Synovial Sarcoma Treatment Production by Type
• 6.2 Global Synovial Sarcoma Treatment Revenue by Type
• 6.3 Synovial Sarcoma Treatment Price by Type

7 Synovial Sarcoma Treatment Segment Market Analysis (by Application)

• 7.1 Global Synovial Sarcoma Treatment Consumption by Application
• 7.2 Global Synovial Sarcoma Treatment Consumption Market Share by Application (2014-2019)

8 Synovial Sarcoma Treatment Major Manufacturers Analysis

• 8.1 Adaptimmune Therapeutics Plc
  • 8.1.1 Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Production Sites and Area Served
  • 8.1.2 Adaptimmune Therapeutics Plc Product Introduction, Application and Specification
  • 8.1.3 Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Advenchen Laboratories LLC
  • 8.2.1 Advenchen Laboratories LLC Synovial Sarcoma Treatment Production Sites and Area Served
  • 8.2.2 Advenchen Laboratories LLC Product Introduction, Application and Specification
  • 8.2.3 Advenchen Laboratories LLC Synovial Sarcoma Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 EpiZyme Inc
  • 8.3.1 EpiZyme Inc Synovial Sarcoma Treatment Production Sites and Area Served
  • 8.3.2 EpiZyme Inc Product Introduction, Application and Specification
  • 8.3.3 EpiZyme Inc Synovial Sarcoma Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Immune Design Corp
  • 8.4.1 Immune Design Corp Synovial Sarcoma Treatment Production Sites and Area Served
  • 8.4.2 Immune Design Corp Product Introduction, Application and Specification
  • 8.4.3 Immune Design Corp Synovial Sarcoma Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Immunocore Ltd
  • 8.5.1 Immunocore Ltd Synovial Sarcoma Treatment Production Sites and Area Served
  • 8.5.2 Immunocore Ltd Product Introduction, Application and Specification
  • 8.5.3 Immunocore Ltd Synovial Sarcoma Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Johnson & Johnson
  • 8.6.1 Johnson & Johnson Synovial Sarcoma Treatment Production Sites and Area Served
  • 8.6.2 Johnson & Johnson Product Introduction, Application and Specification
  • 8.6.3 Johnson & Johnson Synovial Sarcoma Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Karyopharm Therapeutics Inc
  • 8.7.1 Karyopharm Therapeutics Inc Synovial Sarcoma Treatment Production Sites and Area Served
  • 8.7.2 Karyopharm Therapeutics Inc Product Introduction, Application and Specification
  • 8.7.3 Karyopharm Therapeutics Inc Synovial Sarcoma Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Merck & Co Inc
  • 8.8.1 Merck & Co Inc Synovial Sarcoma Treatment Production Sites and Area Served
  • 8.8.2 Merck & Co Inc Product Introduction, Application and Specification
  • 8.8.3 Merck & Co Inc Synovial Sarcoma Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Millennium Pharmaceuticals Inc
  • 8.9.1 Millennium Pharmaceuticals Inc Synovial Sarcoma Treatment Production Sites and Area Served
  • 8.9.2 Millennium Pharmaceuticals Inc Product Introduction, Application and Specification
  • 8.9.3 Millennium Pharmaceuticals Inc Synovial Sarcoma Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Novartis AG
  • 8.10.1 Novartis AG Synovial Sarcoma Treatment Production Sites and Area Served
  • 8.10.2 Novartis AG Product Introduction, Application and Specification
  • 8.10.3 Novartis AG Synovial Sarcoma Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Pfizer Inc
• 8.12 Takara Bio Inc

9 Development Trend of Analysis of Synovial Sarcoma Treatment Market

• 9.1 Global Synovial Sarcoma Treatment Market Trend Analysis
  • 9.1.1 Global Synovial Sarcoma Treatment Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Synovial Sarcoma Treatment Regional Market Trend
  • 9.2.1 North America Synovial Sarcoma Treatment Forecast 2019-2025
  • 9.2.2 Europe Synovial Sarcoma Treatment Forecast 2019-2025
  • 9.2.3 China Synovial Sarcoma Treatment Forecast 2019-2025
  • 9.2.4 Japan Synovial Sarcoma Treatment Forecast 2019-2025
  • 9.2.5 Southeast Asia Synovial Sarcoma Treatment Forecast 2019-2025
  • 9.2.6 India Synovial Sarcoma Treatment Forecast 2019-2025
• 9.3 Synovial Sarcoma Treatment Market Trend (Product Type)
• 9.4 Synovial Sarcoma Treatment Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Synovial Sarcoma Treatment Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List